Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro

Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

Bioprospecting for Anti-COVID-19 Interventions From African Medicinal Plants: A Review - Abidemi J. Akindele, Abimbola Sowemimo, Foluso O. Agunbiade, Margaret O. Sofidiya, Olufunsho Awodele, Omobolanle Ade-Ademilua, Ifeoma Orabueze, Ismail O. Ishola

Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach

Artemisia annua L. and Its Derivatives: Their Antiviral Effects on COVID-19 and Possible Mechanisms

Medicinal Plants as COVID-19 Remedy

Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants - ScienceDirect

IJMS, Free Full-Text

SciELO - Brasil - Approach of utilizing Artemisia herbs to treat covid-19 Approach of utilizing Artemisia herbs to treat covid-19

Robust Antiviral Activity of Santonica Flower Extract (Artemisia cina) against Avian and Human Influenza A Viruses: In Vitro and Chemoinformatic Studies

Small molecules in the treatment of COVID-19

In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

Frontiers Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand

Artemisia annua L. hot-water extracts show potent activity in vitro against Covid-19 variants including delta - ScienceDirect

Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants - ScienceDirect

Frontiers Plant in vitro Culture Technologies; A Promise Into Factories of Secondary Metabolites Against COVID-19